InsiderDB

SEC EDGAR · Company announcement

INM: Acquisition or asset disposal · Financial results

Filed 8-K for an event or period dated 2026-11-16. Acquisition or asset disposal; Financial results.

Follow INM
Became public
Nov 16, 2026, 7:03 AM EST
Event / period date
Nov 16, 2026
Collected
Nov 16, 2026, 7:07 AM EST

Why this is connected

This filing identifies InMed Pharmaceuticals Inc. as the issuer of the security. The company's SEC identifier connects it to INM.

Source evidence

Read the source excerpt or record
Item 2.02. Results of Operations and Financial Condition. The information set forth in Item 2.01 and in Exhibits 99.1 and 99.2 to this Report is incorporated into this Item 2.02 by reference. This Item 2.02 is being furnished to the SEC and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), regardless of any general incorporation language in such filing. Item 9.01 Financial Statements and Exhibits. (a) Financial Statements of Business Acquired The unaudited condensed consolidated financial statements of Mentari as of September 30, 2026 and for the three and nine months ended September 30, 2026 and the related notes thereto are attached as Exhibit 99.1 and are incorporated herein by reference. Also included as Exhibit 99.2 and incorporated herein by reference is Mentari’s Management’s Discussion and Analysis for the three and nine months ended September 30, 2026. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 99.1 Unaudited condensed consolidated financial statements of Mentari as of September 30, 2026 and for the three and nine months ended September 30, 2026 and related notes thereto. 99.2 Mentari’s Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended September 30, 2026. 104 Cover page interactive data file (embedded within the inline XBRL document) SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersi

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.